Table of Contents

company-logo

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. In addition, the company provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium.

Mithra Pharmaceuticals Dividend Announcement

• Mithra Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Mithra Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Mithra Pharmaceuticals Dividend History

Mithra Pharmaceuticals Dividend Yield

Mithra Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Mithra Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Mithra Pharmaceuticals Financial Ratios

P/E ratio-0.09
PEG ratio0.00
P/B ratio-0.14
ROE309.87%
Payout ratio0.00%
Current ratio0.90
Quick ratio0.43
Cash Ratio0.09

Mithra Pharmaceuticals Dividend FAQ

Does Mithra Pharmaceuticals stock pay dividends?
Mithra Pharmaceuticals does not currently pay dividends to its shareholders.
Has Mithra Pharmaceuticals ever paid a dividend?
No, Mithra Pharmaceuticals has no a history of paying dividends to its shareholders. Mithra Pharmaceuticals is not known for its dividend payments.
Why doesn't Mithra Pharmaceuticals pay dividends?
There are several potential reasons why Mithra Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Mithra Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Mithra Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Mithra Pharmaceuticals a dividend aristocrat?
Mithra Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Mithra Pharmaceuticals a dividend king?
Mithra Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Mithra Pharmaceuticals a dividend stock?
No, Mithra Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Mithra Pharmaceuticals stocks?
To buy Mithra Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Mithra Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.